rs1250215

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_212482.4(FN1):​c.4253-15C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.599 in 1,591,364 control chromosomes in the GnomAD database, including 295,208 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.51 ( 21816 hom., cov: 32)
Exomes 𝑓: 0.61 ( 273392 hom. )

Consequence

FN1
NM_212482.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.0390
Variant links:
Genes affected
FN1 (HGNC:3778): (fibronectin 1) This gene encodes fibronectin, a glycoprotein present in a soluble dimeric form in plasma, and in a dimeric or multimeric form at the cell surface and in extracellular matrix. The encoded preproprotein is proteolytically processed to generate the mature protein. Fibronectin is involved in cell adhesion and migration processes including embryogenesis, wound healing, blood coagulation, host defense, and metastasis. The gene has three regions subject to alternative splicing, with the potential to produce 20 different transcript variants, at least one of which encodes an isoform that undergoes proteolytic processing. The full-length nature of some variants has not been determined. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 2-215388316-G-C is Benign according to our data. Variant chr2-215388316-G-C is described in ClinVar as [Benign]. Clinvar id is 1284045.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-215388316-G-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.635 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FN1NM_212482.4 linkc.4253-15C>G intron_variant Intron 26 of 45 ENST00000354785.11 NP_997647.2 P02751-15Q6MZM7Q9UQS6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FN1ENST00000354785.11 linkc.4253-15C>G intron_variant Intron 26 of 45 1 NM_212482.4 ENSP00000346839.4 P02751-15

Frequencies

GnomAD3 genomes
AF:
0.513
AC:
77897
AN:
151976
Hom.:
21813
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.308
Gnomad AMI
AF:
0.608
Gnomad AMR
AF:
0.474
Gnomad ASJ
AF:
0.483
Gnomad EAS
AF:
0.220
Gnomad SAS
AF:
0.542
Gnomad FIN
AF:
0.686
Gnomad MID
AF:
0.402
Gnomad NFE
AF:
0.640
Gnomad OTH
AF:
0.497
GnomAD3 exomes
AF:
0.546
AC:
136948
AN:
250956
Hom.:
39550
AF XY:
0.555
AC XY:
75306
AN XY:
135634
show subpopulations
Gnomad AFR exome
AF:
0.296
Gnomad AMR exome
AF:
0.460
Gnomad ASJ exome
AF:
0.479
Gnomad EAS exome
AF:
0.229
Gnomad SAS exome
AF:
0.557
Gnomad FIN exome
AF:
0.685
Gnomad NFE exome
AF:
0.635
Gnomad OTH exome
AF:
0.558
GnomAD4 exome
AF:
0.608
AC:
875270
AN:
1439270
Hom.:
273392
Cov.:
26
AF XY:
0.607
AC XY:
435728
AN XY:
717548
show subpopulations
Gnomad4 AFR exome
AF:
0.297
Gnomad4 AMR exome
AF:
0.460
Gnomad4 ASJ exome
AF:
0.488
Gnomad4 EAS exome
AF:
0.200
Gnomad4 SAS exome
AF:
0.558
Gnomad4 FIN exome
AF:
0.684
Gnomad4 NFE exome
AF:
0.644
Gnomad4 OTH exome
AF:
0.569
GnomAD4 genome
AF:
0.512
AC:
77927
AN:
152094
Hom.:
21816
Cov.:
32
AF XY:
0.511
AC XY:
37993
AN XY:
74354
show subpopulations
Gnomad4 AFR
AF:
0.308
Gnomad4 AMR
AF:
0.474
Gnomad4 ASJ
AF:
0.483
Gnomad4 EAS
AF:
0.221
Gnomad4 SAS
AF:
0.542
Gnomad4 FIN
AF:
0.686
Gnomad4 NFE
AF:
0.640
Gnomad4 OTH
AF:
0.492
Alfa
AF:
0.502
Hom.:
2879
Bravo
AF:
0.486

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Nov 11, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Glomerulopathy with fibronectin deposits 2 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Spondylometaphyseal dysplasia - Sutcliffe type Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
7.9
DANN
Benign
0.44
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1250215; hg19: chr2-216253039; COSMIC: COSV60551687; COSMIC: COSV60551687; API